Which is Better for Losing Weight: Ozempic or Mounjaro?

Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and tirzepatide are two of the most studied medications for weight management, but they work through different mechanisms in your body. While semaglutide targets the GLP-1 receptor, tirzepatide activates both GLP-1 and GIP receptors, which may explain why clinical trials show tirzepatide produces stronger weight reduction in many patients. Choosing between them depends on your metabolism, genetics, and how your body responds to each compound.

How Semaglutide and Tirzepatide Work Differently

Semaglutide is a GLP-1 receptor agonist, meaning it mimics glucagon-like peptide 1, a natural hormone that signals fullness to your brain and slows stomach emptying. This single-pathway approach has helped millions reduce hunger and lose weight. The medication also improves blood sugar control, which is why it was originally developed for diabetes management.

Tirzepatide uses a dual-action mechanism: it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. By engaging two hormone pathways instead of one, tirzepatide may produce greater satiety signaling and more sustained metabolic changes. Research shows this dual approach can lead to additional weight loss compared to single-pathway medications for some individuals.

Clinical Trial Results: Weight Loss Comparison

In the STEP trials, semaglutide demonstrated an average weight loss of 10 to 15 percent of body weight over 68 weeks at the highest dose. These results were considered groundbreaking when published and established semaglutide as a highly effective weight-management tool. Patients also reported significant improvements in cardiovascular risk factors and quality of life measures.

The SURMOUNT trials for tirzepatide showed average weight loss ranging from 15 to 22 percent of body weight over the same timeframe, with the highest-dose group achieving the most substantial reductions. The difference in outcomes suggests that the dual-pathway approach may offer additional benefit, though individual results vary widely based on genetics, lifestyle, and metabolic factors. Direct comparison studies indicate tirzepatide produced numerically greater reductions in many patient populations.

Genetic Factors That Influence Your Response

Not every person responds identically to either medication, and your genetic makeup plays a significant role in treatment success. Specific variants in the GLP1R gene (like rs6923761) and GIPR gene (rs1800437) influence how sensitively your body responds to these compounds. Additionally, genetic variations in appetite-regulation genes such as FTO and MC4R affect your baseline hunger signals and how dramatically medications can suppress them.

PlexusDx offers the Precision Peptide Genetic Test to map your personal peptide pathways across 14 different systems, analyzing 49 peptides and 150+ genetic insights. This test identifies which GLP-1 or dual-pathway medication may be most effective for your unique biology, helping you avoid trial-and-error approaches. Understanding your genetic predisposition can guide whether semaglutide or tirzepatide aligns better with your metabolic profile.

Side Effects and Tolerability Profiles

Both medications cause similar gastrointestinal side effects, with nausea being the most common during initial weeks of treatment. Semaglutide users typically report mild to moderate nausea that often resolves as the body adjusts. Vomiting, constipation, and diarrhea occur in smaller percentages of patients and usually improve with continued use or dose adjustments.

Tirzepatide carries a comparable side-effect profile but may produce slightly higher rates of nausea in clinical trials, likely because it engages two hormone pathways. However, the additional side effects are typically temporary and manageable. Both medications should be avoided in patients with a personal or family history of medullary thyroid cancer. Starting at lower doses and gradually increasing helps minimize gastrointestinal symptoms, and PlexusDx compounded formulations allow flexible dosing tailored to your tolerance.

Cost and Access Through PlexusDx

PlexusDx compounded semaglutide injections start at $149 per month, while tirzepatide injections begin at $249 per month. Your dose may need to go up. Your price won't—PlexusDx maintains flat monthly pricing regardless of dose level across all three commitment tiers. No insurance is required, no membership fees apply, and all medications come from licensed 503A compounding pharmacies.

PlexusDx also offers oral versions of both medications (oral semaglutide at $249/mo and oral tirzepatide at $279/mo) for patients who prefer non-injection options. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment, helping you and your care provider optimize your medication choice based on your genetic profile. All treatments are HSA and FSA eligible, and PlexusDx serves all 50 states with no geographic restrictions.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Which medication will make me lose more weight: semaglutide or tirzepatide?

Clinical trials show tirzepatide produced greater average weight loss (15-22%) compared to semaglutide (10-15%) in similar patient populations, but individual results depend on your genetics, lifestyle, and how your body responds to each compound. PlexusDx genetic testing can help identify which medication may work better for your specific metabolism.

Why does tirzepatide work differently than semaglutide?

Semaglutide activates only the GLP-1 receptor, while tirzepatide activates both GLP-1 and GIP receptors simultaneously. This dual-pathway approach provides additional signals that reduce hunger, slow digestion, and improve blood sugar control, which may explain the stronger weight-loss results seen in many patients.

How much do these medications cost at PlexusDx?

Compounded semaglutide injections start at $149/month, and tirzepatide injections start at $249/month. Prices remain flat regardless of dose increases, and no insurance is required. Both medications are available in oral formulations as well, with pricing starting at $249/month for oral semaglutide and $279/month for oral tirzepatide.

Are the side effects of semaglutide and tirzepatide the same?

Both medications cause similar gastrointestinal side effects—nausea is most common—but tirzepatide may produce slightly higher rates of nausea in some patients due to its dual-pathway mechanism. Most side effects are temporary and improve as your body adjusts, and starting with lower doses helps minimize discomfort.

How can genetic testing help me choose between semaglutide and tirzepatide?

PlexusDx Precision Peptide Genetic Test analyzes 150+ genetic insights across 14 peptide pathways, including key variants in GLP1R, GIPR, FTO, and MC4R genes that influence your response to each medication. This test helps your provider predict which compound—semaglutide or tirzepatide—will likely work best for your unique biology.

Related Reading

• Ozempic For Losing Weight
• Mounjaro For Losing Weight
• Glp 1 For Losing Weight
• Zepbound For Losing Weight

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.